ASCO® 2026 Highlights: Presenter Vignette – Matteo Carlino

Dr. Matteo Carlino

Matteo Carlino

MD, PhD, FRACP

Westmead and Blacktown Hospitals

9500

Individualized neoantigen therapy intismeran autogene (intismeran) plus pembrolizumab (pembro) in resected melanoma: 5-year update of the KEYNOTE-942 study.